Highlighted Text:
Show |
Hide
Full text loading...
Chapter 33 : Biosafety and Biosecurity: Regulatory Impact
Authors:
Robert J. Hawley,
Theresa D. Duley
Content Type: Reference
Publication Year:
2006
Category: Clinical Microbiology; Applied and Industrial Microbiology
Book DOI:
10.1128/9781555815899
Chapter DOI:
10.1128/9781555815899.ch33
MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.
- « Previous Chapter
- Table of Contents
- Next Chapter »
Preview this chapter:
Biosafety and Biosecurity: Regulatory Impact, Page 1 of 2
< Previous page | Next page > /docserver/preview/fulltext/10.1128/9781555815899/9781555813390_Chap33-1.gif /docserver/preview/fulltext/10.1128/9781555815899/9781555813390_Chap33-2.gif
Abstract:
The Anti-Terrorism and Effective Death Penalty Act of 1996 was passed by Congress after the Larry Wayne Harris incident to control the transport and receipt of hazardous biological agents. The law directed the U.S. Department of Health and Human Services (DHHS) and Centers for Disease Control and Prevention (CDC) to establish new regulatory requirements governing the receipt and transfer of those etiologic agents classified as select agents. In addition to biosafety requirements, the regulation specifies compliance parameters for site threat assessments, inspections, access, training, registration, transfer, record keeping, physical security provisions, and incident reporting, to include notification of loss, theft, or release of agent. Microbiological and Biomedical Laboratories (BMBL) contains the biosafety guidelines and recommendations for work with microbial agents, as determined by the CDC and National Institutes of Health. Training ensures that proper personal protective equipment is donned and functioning properly prior to entry into any containment suite; such equipment may include gloves, Tyvek coveralls, autoclavable shoes or boots, protective eyewear, face masks, and negative-or positive-pressure respirators based on appropriate biosafety level determination. The final select agent rules added the requirement that drills or exercises of security, biosafety, and incident response plans be conducted at least annually. As the environmental parameters and other conditions within the regulatory requirements, guidelines, and recommendations change, facility review committees (e.g., institutional biosafety committees) and timely updates are necessary to reflect those changes.
Citation:
Hawley R, Duley T.
2006.
Biosafety and Biosecurity: Regulatory Impact,
p 587-596.
In
Fleming D, Hunt D (ed),
Biological Safety.
ASM Press, Washington, DC.
doi: 10.1128/9781555815899.ch33
References
/content/book/10.1128/9781555815899.ch33
1.
Anonymous. 1998. What are aerosols and sprays and how are they used to deliver biological weapons? p. 39. In Chem-Bio: Frequently Asked Questions—Guide to Better Understanding Chem-Bio. Version 1.0. Tempest Publishing, Alexandria, Va.
2.
Brown, H. 1998. Emergency response. Occup. Health Safety 67:172.
3.
Burrows, W. D., and, S. E. Renner. 1998. Biological warfare agents as potable water threats, p. 1–5. In W. D. Burrows and S. E. Renner (ed.), Medical Issues Information Paper No. IP-31–017.
4.
Centers for Disease Control and Prevention and National Institutes of Health. 2006. Biosafety in Microbiological and Biomedical Laboratories, 5th ed. L. C. Chasewood and, D. E. Wilson (ed.). U.S. Department of Health and Human Services, Washington, D.C.
5.
Chin, J., and, M. S. Ascher (ed.). 2000. Control of Communicable Diseases Manual. American Public Health Association, Washington, D.C.
6.
Christopher,, G. W.,, T. G. Cieslak,, J. A. Pavlin, and, E. M. Eitzen. 1997. Biological warfare: a historical perspective. JAMA 278:412 –417.
7.
Christopher, G. W., and, E. M. Eitzen. 1999. Air evacuation under high-level biosafety containment: the aeromedical isolation team. Emerg. Infect. Dis. 5: 241– 246.
8.
Dewan,, P. K.,, A. M. Fry,, K. Laserson,, B. C. Tierney,, C. P. Winkelman,, J. A. Hayslett,, L. N. Winkelman,, A. Bosenge,, K. L. Winthrop,, I. Bosenge,, L. Siegel,, T. Bosenge,, V. A. Semenova,, S. Romero-Steiner,, C. Bosenge,, R. Khabbaz,, A. S. Khan,, R. A. Winkelman,, A. Schuchat, and Members of the Washington, D.C., Anthrax Response Team. 2002. Inhalational anthrax outbreak among postal workers, Washington, D.C., 2001. Emerg. Infect. Dis. 8: 1066– 1072.
9.
Eitzen, E.,, J. Pavlin,, T. Cieslak,, G. Christopher, and, R. Culpepper. 1998. Medical Management of Biological Casualties Handbook. U.S. Army Medical Research Institute of Infectious Diseases, Fort Detrick, Md.
10.
Eitzen,, E. M.,, and E. T. Takafuji. 1997. Historical overview of biological warfare, p. 415–423. In F. R. Bosenge,, E. T. Takafuji, and, D. R. Franz (ed.), Medical Aspects of Chemical and Biological Warfare. (TMM series. Part I, warfare, weaponry, and the casualty.) Borden Institute, Walter Reed Army Medical Center, Washington, D.C.
11.
Endicott, S., and, E. Hagerman. 1998. World War II origins, p. 31–35. In S. Endicott and E. Hagerman (ed.), The United States and Biological Warfare: Secrets from the Early Cold War and Korea. Indiana University Press, Bloomington.
12.
Ferguson, J. R. 1997. Biological weapons and U.S. law. JAMA 278: 357– 360.
13.
Franz,, D. R. 1997. Defense against toxin weapons, p. 603–619. In F. R. Sidell,, E. T. Takafuji, and, D. R. Franz (ed.), Medical Aspects of Chemical and Biological Warfare. (TMM series. Part I; warfare, weaponry, and the casualty.) Border Institute, Watter Read Army Medical Center, Washington, D.C.
14.
Harris, S. H. 1995a. Human experiments: “secrets of secrets,” p. 59–66. In S. H. Harris (ed.), Factories of Death, Japanese Biological Warfare 1932–45 and the American Cover-up. Routledge, New York, N.Y.
15.
Harris, S. H. 1995b. The United States BW Program, p. 149–159. In S. H. Harris (ed.), Factories of Death, Japanese Biological Warfare 1932–45 and the American Cover-up. Routledge, New York, N.Y.
16.
International Air Transport Association. 2004. Dangerous Goods Regulations, 45th ed. International Air Transport Association, Montreal, Canada.
17.
Langford, R. E. 2004. Brief history of biological weapons, p. 139–150. In R. E. Langford (ed.), Introduction to Weapons of Mass Destruction. John Wiley & Sons, Inc., Hoboken, N. J.
18.
Manchee, R. J., and, R. Stewart. 1988. The decontamination of Gruinard Island. Chem. Br. 24: 690– 691.
19.
Mangold, T., and, J. Goldberg. 1999a. Arms race, p. 34–36. In T. Mangold and J. Goldberg (ed.), Plague Wars: a True Story of Biological Warfare. Macmillan Publishers Ltd., London, United Kingdom.
20.
Mangold, T., and, J. Goldberg. 1999b. Truth and reconciliation, p. 261–262. In T. Mangold and J. Goldberg (ed.), Plague Wars: a True Story of Biological Warfare. Macmillan Publishers Ltd., London, United Kingdom.
21.
Mitscherlich, A., and, F. Mielke. 1983. Medizin ohne Menschlichkeit: Documente des Nurnberger Arztepoozesses. Fischer Taschenbuchverlag, Frankfurt am Main, Germany.
22.
Morse, S. A. 2002. Bioterrorism: the role of the clinical laboratory. BD Newsl. 13 (1) :1–10.
23.
National Institutes of Health. 2002. NIH Guidelines for Research Involving Recombinant DNA Molecules (NIH Guidelines), 59 FR 34496 (July 5, 1994), as amended. [Online; the current version can be accessed at http://www4.od.nih.gov/oba/rac/guidelines/guidelines.html.]
24.
NATO Handbook on the Medical Aspects of NBC Defensive Operations AMedP-6(B), Part II—Biological. 1996. Medical classification of potential biological warfare agents, p. A-3–A-4. Departments of the Army, the Navy, and the Air Force, Annex A.
25.
Olson, K. B. 1999. Aum Shinrikyo: once and future threat? Emerg. Infect. Dis. 5: 513– 516.
26.
Peters, C. J., and, J. M. Dalrymple. 1990. Alphaviruses, p. 713–761. In B. N. Fields and D. M. Knipe (ed.), Virology, 2nd ed. Raven Press, Ltd., New York, N.Y.
27.
Richmond, J., and, S. Nesby-O’Dell. 2002. Laboratory security and emergency response guidance for laboratories working with select agents. Morb. Mortal. Wkly. Rep. 51(RR-19) : 1– 8.
28.
Snyder, J. W., and, W. Check. 2001. Bioterrorism Threats to Our Future. The Role of the Clinical Microbiology Laboratory in Detection, Identification, and Confirmation of Biological Agents. American Academy of Microbiology, Washington, D.C.
29.
Stern, J. 1999a. Definitions, p. 20. In J. Stern (ed.), The Ultimate Terrorists. Harvard University Press, Cambridge, Mass.
30.
Stern, J. 1999b. Antipersonnel biological warfare agents, p. 164–165. In J. Stern (ed.), The Ultimate Terrorists. Harvard University Press, Cambridge, Mass.
31.
Stern, J. 1999c. Getting and using the weapons, p. 60–65. In J. Stern (ed.), The Ultimate Terrorists. Harvard University Press, Cambridge, Mass.
32.
Traeger,, M. S.,, S. T. Wiersma,, N. E. Rosenstein,, J. M. Malecki,, C. W. Winkelman,, P. L. Raghunathan,, S. P. Winkelman,, T. Bosenge,, C. P. Quinn,, R. F. Winkelman,, S. R. Zaki,, S. Bosenge,, S. M. Bruce,, J. J. Winkelman,, P. M. Dull,, B. C. Winkelman,, J. D. Jones,, B. A. Perkins, and the Florida Investigation Team. 2002. First case of bioterrorism-related inhalational anthrax in the United States, Palm Beach County, Florida, 2001. Emerg. Infect. Dis. 8: 1029– 1034.
33.
Tucker, J. B. 1999. Historical trends related to bioterrorism: an empirical analysis. Emerg. Infect. Dis. 5: 498– 504.
34.
U.S. Department of Agriculture-Agricultural Research Service. 2002. USDA Security Policies and Procedures for Biosafety Level 3 Facilities. USDA department manual 9610-1. U.S. Department of Agriculture-Agricultural Research Service, Washington, D.C.
35.
U.S. Department of Agriculture-Animal and Plant Health Inspection Service. 2002. Title 7 CFR Part 331 and Title 9 CFR Part 121. Agricultural Bioterrorism Protection Act of 2002; Possession, Use, and Transfer of Biological Agents and Toxins; interim final rule. Fed. Regist. 67: 76908– 76938.
36.
U.S. Department of Agriculture-Animal and Plant Health Inspection Service. 2005. Part II. Title 7 CFR Part 331 and Title 9 CFR Part 121. Agricultural Bioterrorism Protection Act of 2002; Possession, Use, and Transfer of Biological Agents and Toxins; final rule. Fed. Regist. 70: 13242– 13292.
37.
U.S. Department of Defense. 2005a. Title 32 Code of Federal Regulations Part 627. Appendix G. Bosenge, p. 580–581. The Biological Defense Safety Program, Technical Safety Requirements(DA Pamphlet 385–69). U.S. Code of Federal Regulations. http://www.gpoaccess.gov/cfr/index.html.
38.
U.S. Department of Defense. 2005b. Title 32 Code of Federal Regulations Part 627.17. Toxins, p. 566–567. The Biological Defense Safety Program, Technical Safety Requirements(DA Pamphlet 385–69) . U.S. Code of Federal Regulations. http://www.gpoaccess.gov/cfr/index.html.
39.
U.S. Department of Defense. 2005c. Title 32 Code of Federal Regulations Part 627. Subpart H. Engineering Controls, p. 567–571. The Biological Defense Safety Program, Technical Safety Requirements(DA Pamphlet 385–69) . U.S. Code of Federal Regulations. http://www.gpoaccess.gov/cfr/index.html.
40.
U.S. Department of Health and Human Services. 2002. Part IV Title 42 CFR Part 73, Office of the Inspector General, Title 42 CFR Part 1003. Possession, Use and Transfer of Select Agents and Toxins; interim final rule. Fed. Regist. 67: 76886– 76905.
41.
U.S. Department of Health and Human Services. 2005. Part III. Title 42 CFR 72 and 73, Office of the Inspector General 42 CFR Part 1003. Possession, Use, and Transfer of Select Agents and Toxins; final rule. Fed. Regist. 70: 13294– 13325.
42.
U.S. Department of Labor. 1991. Title 29 CFR Part 1910. Occupational Safety and Health Standards. Subpart Z. Toxic and Hazardous Substances. Section 1910.1030. Occupational Exposure to Bloodborne Pathogens, final rule. Fed. Regist. 56: 64004– 64182..http://www.osha.gov/pls/oshaweb/owadisp.show_document?p_table-STANDARDS&p_id=10051.
43.
U.S. Department of Labor. 1999. Title 29 CFR Part 1910. Occupational Safety and Health Standards. Subpart Z. Toxic and Hazardous Substances. Section 1910.1450. Occupational Exposure to Hazardous Chemicals in Laboratories, p. 484–538. U.S. Code of Federal Regulations. http://www.gpoaccess.gov/cfr/index.html.
44.
U.S. Department of Transportation. 2003a. Title 49 Code of Federal Regulations Part 173.134. General information, regulations, and definitions, p. 74–1104. U.S. Code of Federal Regulations. http://www.gpoaccess.gov/cfr/index.html.
45.
U. S. Department of Transportation. 2003b. Title 49 Code of Federal Regulations Parts 171–180. Class 6, Division 6.2—Definitions and Exceptions, p. 490–493. U.S. Code of Federal Regulations. http://www.gpoaccess.gov/cfr/index.html.
46.
U.S. Environmental Protection Agency. 2004. Title 40 CFR Part 300. National Oil and Hazardous Substances Pollution Contingency Plan. U.S. Code of Federal Regulations. http://www.gpoaccess.gov/cfr/index.html.
47.
U.S. Public Health Service. 1999. Title 42 CFR Part 71. Foreign Quarantine. Subpart F. Importations. Section 71.54. Etiological Agents, Hosts, and Vectors. U.S. Code of Federal Regulations. http://www.gpoaccess.gov/cfr/index.html.
48.
Wheelis, M. 2002. Biological warfare at the 1346 Siege of Caffa. Emerg. Infect. Dis. 8: 971– 975.
49.
Williams, P., and, D. Wallace. 1989a. The secret of secrets, p. 31–50. In P. Williams and, D. Wallace (ed.), Unit 731: Japan’s Secret Biological Warfare in World War II. MacMillan, Inc., New York, N.Y.
50.
Williams, P., and, D. Wallace. 1989b. Waging germ warfare, p. 68–70. In P. Williams and D. Wallace (ed.), Unit 731: Japan’s Secret Biological Warfare in World War II. MacMillan, Inc., New York, N.Y.
Tables
Biosafety and Biosecurity: Regulatory Impact
[com.pub2web.rdf.cci.facet.ContentItem[id=http://asm.metastore.ingenta.com/content/author/10.1128/9781555815899.ch33-1,webId=/content/author/10.1128/9781555815899.ch33-1,properties={foaf_givenname=Robert J., foaf_name=Robert J. Hawley, foaf_surname=Hawley}], com.pub2web.rdf.cci.facet.ContentItem[id=http://asm.metastore.ingenta.com/content/author/10.1128/9781555815899.ch33-2,webId=/content/author/10.1128/9781555815899.ch33-2,properties={foaf_givenname=Theresa D., foaf_name=Theresa D. Duley, foaf_surname=Duley}]]
Citation:
Hawley R, Duley T.
2006.
Biosafety and Biosecurity: Regulatory Impact,
p 587-596.
In
Fleming D, Hunt D (ed),
Biological Safety.
ASM Press, Washington, DC.
doi: 10.1128/9781555815899.ch33
/content/10.1128/9781555815899.ch33.ch33tab01
TABLE 1
Chronology of additional accounts of biological warfare and terrorism
TABLE 1
Chronology of additional accounts of biological warfare and terrorism
Citation:
Hawley R, Duley T.
2006.
Biosafety and Biosecurity: Regulatory Impact,
p 587-596.
In
Fleming D, Hunt D (ed),
Biological Safety.
ASM Press, Washington, DC.
doi: 10.1128/9781555815899.ch33
/content/10.1128/9781555815899.ch33.ch33tab02
TABLE 2
Select agents and toxins covered by the Select Agent Program
TABLE 2
Select agents and toxins covered by the Select Agent Program
Citation:
Hawley R, Duley T.
2006.
Biosafety and Biosecurity: Regulatory Impact,
p 587-596.
In
Fleming D, Hunt D (ed),
Biological Safety.
ASM Press, Washington, DC.
doi: 10.1128/9781555815899.ch33
/content/10.1128/9781555815899.ch33.ch33tab03
TABLE 3
Attenuated strains of DHHS and USDA agents and toxins excluded from the Select Agent Program
a
TABLE 3
Attenuated strains of DHHS and USDA agents and toxins excluded from the Select Agent Program a
Citation:
Hawley R, Duley T.
2006.
Biosafety and Biosecurity: Regulatory Impact,
p 587-596.
In
Fleming D, Hunt D (ed),
Biological Safety.
ASM Press, Washington, DC.
doi: 10.1128/9781555815899.ch33
/content/10.1128/9781555815899.ch33.ch33tab04
TABLE 4
Attenuated strains of overlap DHHS and USDA agents and toxins excluded from the Select Agent Program
a
TABLE 4
Attenuated strains of overlap DHHS and USDA agents and toxins excluded from the Select Agent Program a
Citation:
Hawley R, Duley T.
2006.
Biosafety and Biosecurity: Regulatory Impact,
p 587-596.
In
Fleming D, Hunt D (ed),
Biological Safety.
ASM Press, Washington, DC.
doi: 10.1128/9781555815899.ch33